Handelsbanken Fonder
EW icon

Handelsbanken Fonder’s Edwards Lifesciences EW Stock Holding History

Handelsbanken Fonder’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139M Buy
1,541,212
+278,208
+22% +$23.3M 0.4% 39
2026
Q1 		$101M Buy
1,263,004
+59,500
+5% +$4.91M 0.34% 51
2025
Q4 		$103M Buy
1,203,504
+840,513
+232% +$69M 0.31% 54
2025
Q3 		$28.2M Sell
362,991
-1,328
-0.4% -$104K 0.09% 204
2025
Q2 		$28.5M Buy
364,319
+139,909
+62% +$10.4M 0.1% 188
2025
Q1 		$16.3M Sell
224,410
-265,755
-54% -$19M 0.07% 261
2024
Q4 		$36.3M Sell
490,165
-643,147
-57% -$45M 0.14% 140
2024
Q3 		$74.8M Sell
1,133,312
-736,665
-39% -$53.5M 0.3% 70
2024
Q2 		$173M Buy
1,869,977
+292,134
+19% +$25.9M 0.75% 19
2024
Q1 		$151M Sell
1,577,843
-32,339
-2% -$2.72M 0.65% 21
2023
Q4 		$123M Buy
1,610,182
+286,095
+22% +$19.9M 0.6% 29
2023
Q3 		$91.7M Buy
1,324,087
+170,300
+15% +$13.7M 0.51% 36
2023
Q2 		$109M Buy
1,153,787
+638,322
+124% +$55.5M 0.58% 30
2023
Q1 		$42.6M Sell
515,465
-28,737
-5% -$2.26M 0.25% 95
2022
Q4 		$40.6M Sell
544,202
-94,237
-15% -$7.26M 0.25% 92
2022
Q3 		$52.8M Buy
638,439
+83,567
+15% +$8.04M 0.35% 57
2022
Q2 		$52.8M Buy
554,872
+22,317
+4% +$2.31M 0.34% 63
2022
Q1 		$62.7M Buy
532,555
+12,712
+2% +$1.43M 0.35% 59
2021
Q4 		$67.3M Sell
519,843
-2,752
-0.5% -$321K 0.33% 64
2021
Q3 		$59.2M Buy
522,595
+18,408
+4% +$2.1M 0.31% 66
2021
Q2 		$52.2M Buy
504,187
+89,269
+22% +$8.41M 0.27% 83
2021
Q1 		$34.7M Buy
414,918
+11,787
+3% +$996K 0.2% 112
2020
Q4 		$36.8M Sell
403,131
-68,407
-15% -$5.67M 0.22% 104
2020
Q3 		$37.6M Buy
471,538
+17,370
+4% +$1.36M 0.28% 82
2020
Q2 		$31.4M Buy
+454,168
New +$32.3M 0.26% 87
2019
Q2 		– Sell
-204,000
Closed -$13M – 191
2019
Q1 		$13M Buy
204,000
+87,000
+74% +$4.96M 0.25% 101
2018
Q4 		$5.97M Sell
117,000
-195,000
-63% -$9.87M 0.12% 139
2018
Q3 		$18.1M Buy
312,000
+78,000
+33% +$3.81M 0.34% 90
2018
Q2 		$11.4M Buy
+234,000
New +$10.9M 0.22% 119
2017
Q1 		– Sell
-85,500
Closed -$2.67M – 172
2016
Q4 		$2.67M Hold
85,500
– – 0.08% 127
2016
Q3 		$3.44M Buy
+85,500
New +$3.22M 0.1% 131
2016
Q2 		– Sell
-60,000
Closed -$1.76M – 237
2016
Q1 		$1.76M Sell
60,000
-67,695
-53% -$1.87M 0.08% 118
2015
Q4 		$3.36M Buy
+127,695
New +$3.32M 0.07% 250

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Handelsbanken Fonder's EW Position: Q2 2026 in Review

Handelsbanken Fonder increased its Edwards Lifesciences (EW) stake by 22% in Q2 2026, buying an estimated $23.3M and bringing the position to 1,541,212 shares worth $139M. The position accounts for 0.4% of the portfolio, ranked #39.

Handelsbanken Fonder first reported a position in EW in Q4 2015 and has held it in 33 quarters since. The position peaked at $173M in Q2 2024. 381 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Handelsbanken Fonder held 1,541,212 shares of Edwards Lifesciences worth $139M as of Q2 2026.
  • Handelsbanken Fonder bought 278,208 Edwards Lifesciences shares in Q2 2026, an estimated $23.3M.
  • Edwards Lifesciences made up 0.4% of Handelsbanken Fonder's portfolio in Q2 2026, its #39 holding.
  • Handelsbanken Fonder first reported a position in Edwards Lifesciences in Q4 2015 and has held it in 33 quarters since.
  • Handelsbanken Fonder's Edwards Lifesciences position peaked at $173M in Q2 2024.
  • 381 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.